tiprankstipranks
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market

Annexon Biosciences (ANNX) Income Statement

Compare
1,166 Followers

Annexon Biosciences Income Statement

Last quarter (Q4 2024), Annexon Biosciences's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Annexon Biosciences's net income was $-48.59M. See Annexon Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -3.27M$ -3.31M$ -3.41M$ -667.00K
Operating Expenses
$ 154.07M$ 143.72M$ 145.60M$ 130.71M$ 63.47M
Depreciation and Amortization
$ 0.00$ 2.15M$ 3.31M$ 3.41M$ 667.00K
EBITDA
$ -154.07M$ -141.57M$ -143.49M$ -128.57M$ -62.80M
Operating Income
$ -154.07M$ -143.72M$ -145.60M$ -130.71M$ -63.47M
Other Income/Expenses
$ 15.87M$ 9.49M$ 3.65M$ 390.00K$ 57.00K
Pretax Income
$ -138.20M$ -134.24M$ -141.95M$ -130.32M$ -63.41M
Net Income
$ -138.20M$ -134.24M$ -138.29M$ -127.79M$ -62.74M
Per Share Metrics
Basic EPS
$ -1.01$ -1.77$ -2.53$ -3.34$ -3.70
Diluted EPS
$ -1.01$ -1.77$ -2.53$ -3.34$ -3.70
Weighted Average Shares Outstanding
137.40M 75.67M 54.67M 38.32M 16.96M
Weighted Average Shares Outstanding (Diluted)
137.40M 75.67M 54.67M 38.32M 16.96M
Currency in USD

Annexon Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis